Lv1
50 积分 2026-03-10 加入
Downregulation of CHCHD2 may Contribute to Parkinson’s Disease by Reducing Expression of NFE2L2 and RQCD1
2天前
待确认
Baseline Amyloid PET Centiloid Score and Risk of Amyloid-Related Imaging Abnormalities in Patients Treated With Lecanemab
16天前
已完结
Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
1个月前
已完结
Initial Real-World Evidence for Lecanemab in the United States
5个月前
已完结
Implementation and service impact of anti-amyloid therapy in a psychiatry-led dementia care program: Real-world evidence from a Japanese regional dementia center
5个月前
已完结
PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of Patients with Alzheimer Disease undergoing Anti-Amyloid Therapy
5个月前
已完结
Association between dietary fat intake and long-term risk of dementia: a prospective cohort study
5个月前
已完结
Real-World Experience with Long-term Lecanemab Treatment: A Retrospective Chart Review in Early Alzheimer’s Disease
7个月前
已关闭
A Retrospective Analysis of Amyloid-Related Imaging Abnormalities in Apolipoprotein E e4 Homozygote Patients Treated with Lecanemab for Alzheimer's Disease in Routine Clinical Practice
7个月前
已完结
Lecanemab Treatment in Real World Settings in the United States
7个月前
已关闭
皖公网安备34019202002308
